- Jazz is seeking a court order blocking sales of Avadel’s proposed drug and blocking Avadel from practicing any methods covered by patents, and cash compensation if Avadel has “committed any acts” related to compositions or methods in patents, according to
complaintfiled Wednesday in federal court in Wilmington, Delaware
- Avadel said during Monday
earnings callit has “accelerated” its launch for its proposed drug, known as FT218, complaint says
- Patents cover methods of use and administration of sodium oxybate, complaint says ...
May 13, 2021, 3:03 PM